Literature DB >> 29500184

IPMNs with co-occurring invasive cancers: neighbours but not always relatives.

Matthäus Felsenstein1,2, Michaël Noë1, David L Masica3,4, Waki Hosoda1, Peter Chianchiano1, Catherine G Fischer1, Gemma Lionheart1, Lodewijk A A Brosens5, Antonio Pea6, Jun Yu7, Georgios Gemenetzis7, Vincent P Groot7,8, Martin A Makary7, Jin He7, Matthew J Weiss7, John L Cameron7, Christopher L Wolfgang7, Ralph H Hruban1,9, Nicholas J Roberts1, Rachel Karchin3,4, Michael G Goggins1,9, Laura D Wood1,9.   

Abstract

OBJECTIVE: Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions that can give rise to invasive pancreatic carcinoma. Although approximately 8% of patients with resected pancreatic ductal adenocarcinoma have a co-occurring IPMN, the precise genetic relationship between these two lesions has not been systematically investigated.
DESIGN: We analysed all available patients with co-occurring IPMN and invasive intrapancreatic carcinoma over a 10-year period at a single institution. For each patient, we separately isolated DNA from the carcinoma, adjacent IPMN and distant IPMN and performed targeted next generation sequencing of a panel of pancreatic cancer driver genes. We then used the identified mutations to infer the relatedness of the IPMN and co-occurring invasive carcinoma in each patient.
RESULTS: We analysed co-occurring IPMN and invasive carcinoma from 61 patients with IPMN/ductal adenocarcinoma as well as 13 patients with IPMN/colloid carcinoma and 7 patients with IPMN/carcinoma of the ampullary region. Of the patients with co-occurring IPMN and ductal adenocarcinoma, 51% were likely related. Surprisingly, 18% of co-occurring IPMN and ductal adenocarcinomas were likely independent, suggesting that the carcinoma arose from an independent precursor. By contrast, all colloid carcinomas were likely related to their associated IPMNs. In addition, these analyses showed striking genetic heterogeneity in IPMNs, even with respect to well-characterised driver genes.
CONCLUSION: This study demonstrates a higher prevalence of likely independent co-occurring IPMN and ductal adenocarcinoma than previously appreciated. These findings have important implications for molecular risk stratification of patients with IPMN. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer genetics; carcinogenesis; molecular genetics; mutations; pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 29500184     DOI: 10.1136/gutjnl-2017-315062

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  36 in total

1.  Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.

Authors:  Karoliina Stefanius; Kelly Servage; Marcela de Souza Santos; Hillery Fields Gray; Jason E Toombs; Suneeta Chimalapati; Min S Kim; Venkat S Malladi; Rolf Brekken; Kim Orth
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

2.  Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.

Authors:  Catherine G Fischer; Violeta Beleva Guthrie; Alicia M Braxton; Lily Zheng; Pei Wang; Qianqian Song; James F Griffin; Peter E Chianchiano; Waki Hosoda; Noushin Niknafs; Simeon Springer; Marco Dal Molin; David Masica; Robert B Scharpf; Elizabeth D Thompson; Jin He; Christopher L Wolfgang; Ralph H Hruban; Nicholas J Roberts; Anne Marie Lennon; Yuchen Jiao; Rachel Karchin; Laura D Wood
Journal:  Gastroenterology       Date:  2019-06-05       Impact factor: 22.682

Review 3.  Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Takao Ohtsuka; Takahiro Tomosugi; Ryuichiro Kimura; So Nakamura; Yoshihiro Miyasaka; Kohei Nakata; Yasuhisa Mori; Makiko Morita; Nobuhiro Torata; Koji Shindo; Kenoki Ohuchida; Masafumi Nakamura
Journal:  Surg Today       Date:  2019-03-16       Impact factor: 2.549

4.  Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.

Authors:  Hidemasa Kawabata; Yusuke Ono; Nobue Tamamura; Kyohei Oyama; Jun Ueda; Hiroki Sato; Kenji Takahashi; Kenzui Taniue; Tetsuhiro Okada; Syugo Fujibayashi; Akihiro Hayashi; Takuma Goto; Katsuro Enomoto; Hiroaki Konishi; Mikihiro Fujiya; Keita Miyakawa; Mishie Tanino; Yuji Nishikawa; Daisuke Koga; Tsuyoshi Watanabe; Chiho Maeda; Hidenori Karasaki; Andrew S Liss; Yusuke Mizukami; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2022-01-11       Impact factor: 7.527

Review 5.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

6.  Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.

Authors:  Anne Macgregor-Das; Jun Yu; Koji Tamura; Toshiya Abe; Masaya Suenaga; Koji Shindo; Michael Borges; Chiho Koi; Shiro Kohi; Yoshihiko Sadakari; Marco Dal Molin; Jose A Almario; Madeline Ford; Miguel Chuidian; Richard Burkhart; Jin He; Ralph H Hruban; James R Eshleman; Alison P Klein; Christopher L Wolfgang; Marcia I Canto; Michael Goggins
Journal:  J Mol Diagn       Date:  2020-03-20       Impact factor: 5.568

Review 7.  From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.

Authors:  Catherine G Fischer; Laura D Wood
Journal:  J Pathol       Date:  2018-12       Impact factor: 7.996

8.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Authors:  Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno
Journal:  Gut       Date:  2019-10-31       Impact factor: 23.059

9.  Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.

Authors:  Kohei Fujikura; Waki Hosoda; Matthäus Felsenstein; Qianqian Song; Johannes G Reiter; Lily Zheng; Violeta Beleva Guthrie; Natalia Rincon; Marco Dal Molin; Jonathan Dudley; Joshua D Cohen; Pei Wang; Catherine G Fischer; Alicia M Braxton; Michaël Noë; Martine Jongepier; Carlos Fernández-Del Castillo; Mari Mino-Kenudson; C Max Schmidt; Michele T Yip-Schneider; Rita T Lawlor; Roberto Salvia; Nicholas J Roberts; Elizabeth D Thompson; Rachel Karchin; Anne Marie Lennon; Yuchen Jiao; Laura D Wood
Journal:  Gut       Date:  2020-10-07       Impact factor: 23.059

Review 10.  Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate.

Authors:  Mahmoud Aldyab; Tony El Jabbour; Megan Parilla; Hwajeong Lee
Journal:  World J Gastrointest Surg       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.